Sage Therapeutics to Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022
April 19 2022 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical
company leading the way to create a world with better brain health,
announced today that it will host a live webcast on Tuesday, May 3,
2022 at 8:00 a.m. ET to announce first quarter 2022 financial
results and discuss recent business updates.
The webcast can be accessed on the Investor page of Sage’s
website at investor.sagerx.com. A replay of the webcast will be
available approximately two hours after the completion of the event
and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly
leading the way to create a world with better brain health. Our
mission is to pioneer solutions to deliver life-changing brain
health medicines, so every person can thrive. For more information,
please visit. www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220413005785/en/
Investor Helen Rubinstein 315-382-3979
helen.rubinstein@sagerx.com
Media Becky Kern 914-772-2310 becky.kern@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2023 to Aug 2024